This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

E-health Intervention for Cancer Survivors 2.0

This study has been withdrawn prior to enrollment.
(Study ended prior to completion of planning stage. No participants enrolled.)
Sponsor:
Information provided by (Responsible Party):
David Mohr, Northwestern University
ClinicalTrials.gov Identifier:
NCT01348997
First received: May 4, 2011
Last updated: October 6, 2014
Last verified: October 2014
  Purpose
This study will develop and examine the effectiveness of an intervention that utilizes technology to improve cancer survivors' access to mental health care and increase their ability to manage the stressors involved in cancer survivorship. The intervention, referred to as Project Onward, uses an interactive website and an online social network. The purpose of this study is to pilot a novel intervention that can reduce costs, examine methods to improve adherence to internet based treatment and overcome numerous barriers to treatment for mental health concerns.

Condition Intervention Phase
Cancer Behavioral: Project Onward website + 16 person social network Behavioral: Project Onward website + 8 person social network Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: E-Health Intervention for Cancer Survivors 2.0

Further study details as provided by David Mohr, Northwestern University:

Primary Outcome Measures:
  • Depression, as measured by the Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Measured at baseline, 4 weeks, 8 weeks and 12 weeks ]
  • Anxiety, as measured by the Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Measured at baseline, 4 weeks, 8 weeks and 12 weeks ]

Secondary Outcome Measures:
  • Website utilization (e.g., number of logins, average visit length, total time spent on the site, number of exercises completed) [ Time Frame: From baseline through 12 weeks ]

Enrollment: 0
Study Start Date: May 2011
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Project Onward website + 16 person social network Behavioral: Project Onward website + 16 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 16 other cancer survivors.
Active Comparator: Project Onward website + 8 person social network Behavioral: Project Onward website + 8 person social network
The website will include 8 weeks of Internet-based cognitive behavioral therapy combined with discussion and support from a group of up to 8 other cancer survivors.

Detailed Description:

Nearly 65% of those with cancer diagnoses will survive for at least 5 years, with approximately 10.5 million cancer survivors in the United States. The time of transition for cancer patients, from active treatment to survivorship, has been identified as a time of high risk for depression and anxiety. Cancer survivors experience higher rates of anxiety and depression than those without a cancer history. Research has identified fear of recurrence, perceived loss of support, and social pressure to resume a "normal" life, among other phenomena, as sources for this emotional distress. However, only about 20% of all patients referred for psychotherapy ever enter treatment and of those who initiate treatment, nearly half drop out before completion. This suggests that there are significant barriers to receiving care. These barriers may be even higher for cancer survivors struggling with issues related to re-entry, such as returning to work, resuming household responsibilities and managing residual symptoms such as fatigue or pain.

The internet promises to provide inexpensive access to treatment at any time of the day or night. Unfortunately, the potential for internet delivered services has not been realized. Studies examining treatments that simply provide access to an internet site commonly result in very high dropout after the first site visit, and typically little or no improvement target symptoms. A variety of methods to improve responses to internet interventions have been examined. In general, e-mail support improves adherence and telephone support can improve adherence even more. Another type of support that has only begun to be investigated is the use of social networks to help maintain adherence.

This intervention will use an online social network, to increase adherence and promote the use of the website and the skills it teaches.

  Eligibility

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Any cancer diagnosis.
  • Has completed treatment for cancer and is currently in full remission.
  • ECOG performance Status of < 3.
  • Has a telephone, e-mail account, computer, and broadband access to the Internet.
  • Has familiarity with using the Internet that allows for adequate navigation of website.
  • Is able to speak and read English.
  • Is at least 19 years of age.
  • Is able to give informed consent.

Exclusion Criteria:

  • Has visual impairment that would prevent use of the website and completion of assessment materials.
  • Diagnosis of basal or squamous cell skin cancers.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01348997

Locations
United States, Illinois
Northwestern University
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
Investigators
Principal Investigator: David C. Mohr, Ph.D. Northwestern University
  More Information

Responsible Party: David Mohr, Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT01348997     History of Changes
Other Study ID Numbers: NU Lurie 10CC01
Study First Received: May 4, 2011
Last Updated: October 6, 2014

Keywords provided by David Mohr, Northwestern University:
cancer
cancer survivors
internet
depression
anxiety

ClinicalTrials.gov processed this record on June 23, 2017